期刊文献+

曲古抑菌素A单用及联用伊马替尼对K562R细胞增殖和凋亡的影响 被引量:1

Effect of trichostatin alone and combination with imatinb on the proliferation and apoptosis of the K562R cells
下载PDF
导出
摘要 目的:探讨曲古抑菌素A(trichostatin A,TSA)对耐伊马替尼细胞株K562R的增殖和凋亡的影响。方法:采用3-(4,5-二甲基-2-基)-5(3-羧基甲基苯基)-2-(4-磺酸苯基)-2H-四氮唑细胞毒试验法观察细胞增殖抑制,细胞凋亡率采用流式细胞仪凋亡试剂盒检测。结果:TSA单用能抑制K562R细胞的增殖,呈时间剂量依赖性,并能促进凋亡。与伊马替尼联用有明显协同作用。结论:TSA与伊马替尼联用具有明显抑制耐伊马替尼的K562R增殖和诱导凋亡的作用,可能为临床伊马替尼耐药的患者提供新的治疗药物。 Objective To explore the effect of trichostatin A (TSA) alone and combination with imatinib on the proliferation and apoptosis of K562R cells.Methods 3-(4,5-dimethylthiazol-2-yl) -5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium(MTS) assay was used to observe the proliferation of K562R cells and apoptosis was analyzed by annexin-Ⅴ/propidium iodide(PI) staining.Results After exposure to TSA,the proliferation of K562R cells was inhibited,and the effect was in both time- and dose-dependent manner.The apoptosis was induced.Combined with imatinib,the effect of proliferation inhibition was better.Conclusion TSA combined with imatinib can inhibit the proliferation of K562R cells and induce its apopotosis.TSA may become a new drug for imatinib-resistant patients.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2011年第8期782-785,共4页 Journal of Central South University :Medical Science
关键词 曲古抑菌素A 伊马替尼 耐药 增殖 凋亡 trichostatin imatinb drug-resistant proliferation apoptosis
  • 相关文献

参考文献10

  • 1李咏,李电东,何琪杨.组蛋白去乙酰化酶抑制剂调节肿瘤细胞多药耐药性的机制[J].中国新药杂志,2008,17(15):1295-1297. 被引量:9
  • 2齐静,彭晖,顾振纶,梁中琴,杨纯正.伊马替尼耐药的K562细胞系的建立及其生物学特性研究[J].中华血液学杂志,2004,25(6):337-341. 被引量:20
  • 3Mohammad S H, Thorsten H, Christoph E. TSA downregulates Wilmstumor genel ( WT1 ) expression at multiple levels [ J]. Nucleic Acids Res, 2008, 36(12) :4067-4078. 被引量:1
  • 4Giuseppe L, Francesco D, Giuseppe Z, et al. Epigenetic treatment of myelodysplastic syndrome and acute myeloid leukemia [J]. Curr Med Chemist, 2008, 15(13) :1274-1287. 被引量:1
  • 5Lee S M, Bae J H, Kim M J, et al. Bcr-abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitor [ J ]. JPET, 2007, 322 (3) : 1084-1092. 被引量:1
  • 6Wasren F, Micheal P, Maria B, et al. Cotreatment with vorinostate (suberoylanilide hydroxanic acid ) enhance activity of dasatinib (BMS-354825)against imtinib mesylate-sensitive or imatinib-resistant chronic myelogenous leukemia cells [ J ]. Clinc Cancer Res, 2006, 12(19) :5869-5875. 被引量:1
  • 7Yu C, Rahmani M,Alemenara J, et al. Hisyone deacetylase inhibitors promote ST1571-mediated apoptosis in ST1571-sensitive and-resistant Bcr/Abl^+ human myeloid leukemia cells [J]. Cancer Res, 2003, 63(9): 2118-2126. 被引量:1
  • 8Dasmahapatra G, Yerram N, Dai Y, et al. Synergistic interaction between vorinostat and sorafenib in chronic myelogenous leukemia ceils involve MCL-1 and 1721 CIPI down-regulaton [ J ]. Clin Cancer Res, 2007,13 (14) : 4280-4290. 被引量:1
  • 9Nalon L, Jahnson P W M, Ganesan A, et al. Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential? [ J]. Br J Cancer, 2008,99 (5) :689-694. 被引量:1
  • 10黄轶群,马旭东.组蛋白乙酰化与白血病[J].白血病.淋巴瘤,2006,15(2):145-148. 被引量:2

二级参考文献62

  • 1GOTTESMAN MM, FOJO T, BATES SE. Multidrug resistance in cancer: role of ATP-dependent transporters [ J ]. Nat Rev Cancer, 2002,2( 1 ) : 48 - 58. 被引量:1
  • 2KRUTH GD, BELINSKY MG. The MRP family of drug efflux pumps[J]. Oncogene, 2003, 22(47):7537-7552. 被引量:1
  • 3BAKER EK, EL-OSTA A. The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer [ J ]. Exp Cell Res, 2003, 290(2) : 177 - 194. 被引量:1
  • 4KOUZARIDES T. Chromatin modifications and their function [J]. Cell, 2007, 128(3): 693 -705. 被引量:1
  • 5BORDONE L, GUARENTE L. Calorie restriction, SIRT1 and metabolism: understanding longevity [ J ]. Nat Rev Mol Cell Biol, 2005, 6(4): 298 -305. 被引量:1
  • 6MARCHION D, MUNSTER P. Development of histone deacetylase inhibitors for cancer treatment [ J ]. Expert Rev Anticancer Ther, 2007, 7(4) : 583 -598. 被引量:1
  • 7LEGGAS M, PANETTA JC, ZHUANG Y, et al. Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo[J]. CancerRes, 2006, 66(9): 4802 -4807. 被引量:1
  • 8RUEFLI AA, AUSSERLECHNER MJ, BERNHARD D, et al. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species[J], Proc Natl Acad Sci, 2001, 98(19): 10833 - 10838. 被引量:1
  • 9RUEFLI AA, BERNHARD D, TAINTON KM, et al. Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells[J]. Int J Cancer, 2002, 99(2) :292 -298. 被引量:1
  • 10TANG R, FAUSSAT AM, MAJDAK P, et al. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRPI [ J ]. Leukemia, 2004, 18 (7) :1246 - 1251. 被引量:1

共引文献28

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部